DigestScience

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. The company's research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body's own terms to enable doctors to combat numerous diseases and medical conditions.

The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world.

http://www.ferring.com

Founded in 1889, over the years Giuliani has successfully developed high-quality products and has contributed to promoting pharmaceutical awareness among the public, becoming one of Italy's time-honored, well known and highly esteemed pharmaceutical manufacturers.
The company aims to consolidate its leadership by continually launching innovative products and entering emerging markets consistently with its know how.

The company continues to focus on the gastrointestinal, nutraceutical and Dermatological areas.

http://www.giulianipharma.com/eng/index.htm

With over 55,000 employees globally, Schering-Plough is one of the world's largest pharmaceutical companies.

It has developed several innovative treatments for inflammatory bowel diseases.

http://www.sch-plough.com

The François Aupetit Association is a registered charity for French IBD patients.

The AFA funds many research programmes in this field and thus very naturally linked up with the DigestScience foundation in order to help fund research on these very widespread digestive tract diseases.

http://www.afa.asso.fr

The AFDIAG was founded by patients suffering from coeliac disease.

In addition to its goal of informing, helping and defending patients, the AFDIAG is very involved in research - notably through its membership of the GERMC (the Coeliac Disease Research and Study Group). www.afdiag.org

http://www.afdiag.org

MICI -VIDI-VICI is a recently-formed IBD patient association which has followed on from the success of the lacrohnique.com web site.

http://www.lacrohnique.com/smartsection.item.60/association-mici-vidi-vici-et-le-site-la-crohnique.html

Lille University Medical Centre comprises 11 hospitals and is the largest university hospital complex in northern Europe.

Lille University Medical Centre has unique expertise in digestive tract disease and is particularly committed to research and clinical trials in a region that is highly affected by Crohn's disease. Its involvement demonstrates the intention of seeing DigestScience-funded research rapidly translated into actual patient care.

http://www.chru-lille.fr

The INSERM includes France's best medical research groups and is the only national research institute entirely dedicated to human health.

Its participation in DigestScience testifies to the foundation's intention to federate research promoters around the issue of digestive tract diseases.

http://www.inserm.fr

With almost 30,000 students, the University of Lille 2 is one of Europe's major higher education institutions, notably in the field of healthcare.

Medical research is very important at the University of Lille 2 and the latter's participation in DigestScience's activities underlines its commitment to projects which advance scientific and medical research, healthcare, teaching and training.

http://www.univ-lille2.fr

La mission de pilotage et d'orientation stratégique du système de recherche est aujourd'hui confiée au ministère de l'enseignement supérieur et de la recherche. Via sa direction générale de la recherche et de l'innovation (DGRI), il a un rôle central aux côtés des autres ministères concernés, dans l'élaboration de la politique nationale de recherche.

www.enseignementsup-recherche.gouv.fr